TNFAIP2 Polyclonal antibody
TNFAIP2 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human and More (1)
Applications
WB, ELISA
Conjugate
Unconjugated
Cat no : 25649-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive WB detected in | HeLa cells, HepG2 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
WB | See 2 publications below |
Product Information
The immunogen of 25649-1-AP is TNFAIP2 Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Cited Reactivity | human, canine |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | TNFAIP2 fusion protein Ag19150 相同性解析による交差性が予測される生物種 |
Full Name | tumor necrosis factor, alpha-induced protein 2 |
Calculated molecular weight | 654 aa, 73 kDa |
Observed molecular weight | 73 kDa |
GenBank accession number | BC128449 |
Gene symbol | TNFAIP2 |
Gene ID (NCBI) | 7127 |
RRID | AB_2918092 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
TNFAIP2, also named as B94, belongs to the SEC6 family. TNFAIP2 may play a role as a mediator of inflammation and angiogenesis. TNFAIP2 is differentially expressed in development and capillary tube-like formation in vitro. It is induced by TNFα and other proinflammatory factors.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for TNFAIP2 antibody 25649-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cell Commun Signal NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression |